June 20, 2019
Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) on Wednesday formally introduced a wide-ranging bill to address so-called "surprise" medical bills that would establish a benchmark provider payment rate for out-of-network services, instead of the arbitration process favored by hospital industry groups.
Valisure, an online pharmacy, in a filing to FDA last week said it discovered the carcinogen dimethylformamide in the common heart drug valsartan—marking the fourth carcinogen found in the drug.
CMS on Monday proposed a rule intended to streamline Medicare Part D's electronic prior authorization process by circumventing certain HIPAA requirements.
June 19, 2019
U.S. residents increasingly are visiting Canada to purchase insulin, as costs for the diabetes treatment in the United States have spiked in recent years.
About 169.1 million doses of the seasonal influenza vaccine were administered last flu season, and about 200 patients received expired vaccines—though the real figure might be higher, according to a CDC report published Friday.
June 17, 2019
Three pharmaceutical companies and the Association of National Advertisers on Friday filed a lawsuit challenging HHS' final rule to require drugmakers to disclose their products' list prices in consumer-directed television advertisements, claiming the final rule exceeds HHS' statutory authority and violates the First Amendment of the Constitution.
The median total costs insurers and patients paid for the 49 most popular prescription drugs in the United States, by sales, increased between 2012 and 2017, with many of those costs increasing more than twofold, according to a recent study.
June 14, 2019
CMS on Wednesday approved Washington's plan to negotiate value-based drug agreements with the makers of hepatitis C treatments under a subscription-like model.
American Health Line rounds up the latest health care news in the states.
Advisory Board. All rights reserved.